BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22100139)

  • 1. Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives.
    Lee CC; Huang KF; Lin PY; Huang FC; Chen CL; Chen TC; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2012 Jan; 47(1):323-36. PubMed ID: 22100139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones.
    Lee CC; Huang KF; Chang DM; Hsu JJ; Huang FC; Shih KN; Chen CL; Chen TC; Chen RH; Lin JJ; Huang HS
    Eur J Med Chem; 2012 Apr; 50():102-12. PubMed ID: 22357112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
    Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
    Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones.
    Huang HS; Chou CL; Guo CL; Yuan CL; Lu YC; Shieh FY; Lin JJ
    Bioorg Med Chem; 2005 Mar; 13(5):1435-44. PubMed ID: 15698759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
    Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
    J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
    Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, telomerase evaluation and anti-proliferative studies on various series of diaminoanthraquinone-linked aminoacyl residue derivatives.
    Huang FC; Huang KF; Chen RH; Wu JE; Chen TC; Chen CL; Lee CC; Chen JY; Lin JJ; Huang HS
    Arch Pharm (Weinheim); 2012 Feb; 345(2):101-11. PubMed ID: 21956661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSC746364, NSC746365, and NSC746366: the spectra of cytotoxicity and molecular correlates of response to telomerase activity.
    Huang HS; Huang KF; Lee CC; Chen CL; Li CL; Lin JJ
    Anticancer Drugs; 2010 Feb; 21(2):169-80. PubMed ID: 19884821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
    Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
    Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
    Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.
    Chen TC; Yu DS; Huang KF; Fu YC; Lee CC; Chen CL; Huang FC; Hsieh HH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Nov; 69():278-93. PubMed ID: 24051300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and antiproliferative activities of biarylolefins based on polyhydroxylated and carbohydrate scaffolds.
    Novoa A; Pellegrini-Moïse N; Bourg S; Thoret S; Dubois J; Aubert G; Cresteil T; Chapleur Y
    Eur J Med Chem; 2011 Sep; 46(9):3570-80. PubMed ID: 21636180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
    Taher AT; Hegazy GH
    Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues.
    Huang HS; Chen TC; Chen RH; Huang KF; Huang FC; Jhan JR; Chen CL; Lee CC; Lo Y; Lin JJ
    Bioorg Med Chem; 2009 Nov; 17(21):7418-28. PubMed ID: 19804981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones.
    Huang HS; Chen IB; Huang KF; Lu WC; Shieh FY; Huang YY; Huang FC; Lin JJ
    Chem Pharm Bull (Tokyo); 2007 Feb; 55(2):284-92. PubMed ID: 17268103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.
    Luo Y; Zhang S; Qiu KM; Liu ZJ; Yang YS; Fu J; Zhong WQ; Zhu HL
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1091-5. PubMed ID: 23312949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors.
    Fan ZF; Ho ST; Wen R; Fu Y; Zhang L; Wang J; Hu C; Shaw PC; Liu Y; Cheng MS
    Molecules; 2019 Sep; 24(17):. PubMed ID: 31480619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.